These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16465370)

  • 1. The impact of aggregation on the biodistribution of hypericin.
    Van De Putte M; Roskams T; Bormans G; Verbruggen A; De Witte PA
    Int J Oncol; 2006 Mar; 28(3):655-60. PubMed ID: 16465370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy.
    Chung PS; Saxton RE; Paiva MB; Rhee CK; Soudant J; Mathey A; Foote C; Castro DJ
    Laryngoscope; 1994 Dec; 104(12):1471-6. PubMed ID: 7990636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder.
    Huygens A; Kamuhabwa AR; van Cleynenbreugel B; van Poppel H; Roskams T; de Witte PA
    BJU Int; 2005 Feb; 95(3):436-41. PubMed ID: 15679810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the tumoritropic principle of hypericin.
    Van de Putte M; Roskams T; Vandenheede JR; Agostinis P; de Witte PA
    Br J Cancer; 2005 Apr; 92(8):1406-13. PubMed ID: 15812555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.
    Van de Putte M; Wang H; Chen F; de Witte PA; Ni Y
    Acad Radiol; 2008 Jan; 15(1):107-13. PubMed ID: 18078913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
    Boiy A; Roelandts R; van den Oord J; de Witte PA
    Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of application and formulation factors on the penetration of hypericin in normal mouse skin and UV induced skin tumors.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2007 Dec; 89(2-3):156-62. PubMed ID: 17983765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model.
    Van de Putte M; Wang H; Chen F; De Witte PA; Ni Y
    Oncol Rep; 2008 Apr; 19(4):927-32. PubMed ID: 18357377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma.
    Chung PS; Rhee CK; Kim KH; Paek W; Chung J; Paiva MB; Eshraghi AA; Castro DJ; Saxton RE
    Laryngoscope; 2000 Aug; 110(8):1312-6. PubMed ID: 10942132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
    Van de Putte M; Ni Y; De Witte PA
    Oncol Rep; 2008 Apr; 19(4):921-6. PubMed ID: 18357376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour activity of photosensitized hypericin on A431 cell xenografts.
    Vandenbogaerde AL; Geboes KR; Cuveele JF; Agostinis PM; Merlevede WJ; De Witte PA
    Anticancer Res; 1996; 16(4A):1619-25. PubMed ID: 8712679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
    Chen B; de Witte PA
    Cancer Lett; 2000 Mar; 150(1):111-7. PubMed ID: 10755394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
    Kamuhabwa AA; Roskams T; Baert L; De Witte PA
    Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results.
    Noell S; Mayer D; Strauss WS; Tatagiba MS; Ritz R
    Int J Oncol; 2011 May; 38(5):1343-8. PubMed ID: 21399870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
    Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
    Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes.
    Derycke AS; De Witte PA
    Int J Oncol; 2002 Jan; 20(1):181-7. PubMed ID: 11743662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA; Huygens A; De Witte PA
    Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.